Evidence indicates that the microbiome plays an essential role in response to cancer immunotherapy and multiple conditions. These include Parkinson’s disease, Alzheimer’s disease, schizophrenia, autism and anxiety via the gut-brain axis.

These microbiome frontiers emerge as exciting areas of interest with significant growth areas for healthcare and food companies. Meanwhile fundamental insights on the role of the microbiome in these complex diseases are needed to enable the development of microbiota-targeted diagnosis and/or therapies.

The region is home to excellent research centres conducting interdisciplinary, cutting-edge biomedical research within the areas of metabolism, stem cells, cancer, and neurobiology. Therefore, the region is well-positioned to frontier these exciting areas together with regional companies such as the international pharmaceutical company Lundbeck, which is focusing on central nervous system disorders (CNS).

Examples of biomedical research centres in the region supporting research in oncology and neuroscience

The Neuroscience Centre conducts research on diagnostic evaluation, treatment, rehabilitation and care for patients with neurological disorders

The Novo Nordisk Foundation Center for Stem Cell Biology conducts basic research solving complex problems in stem cell and developmental biology

Lund Stem Cell Center is a world-leading center for stem cell research

Biotech Research & Innovation Centre (BRIC) is an elite centre conducting basic research on cancer, neurological and metabolic disease

National Center for Cancer Immune Therapy focuses on development of immunological treatment of cancer

The Novo Nordisk Foundation Center for Basic Metabolic Research studies the fundamental mechanisms and biological pathways that underlie metabolic health and disease

The Novo Nordisk Foundation Center for Protein Research explores protein modifications in health and disease

Lund University Cancer Centre (LUCC) is a cancer organisation at Lund University

The CREATE Health Cancer Centre develops biomarkers for early diagnosis and improved treatment of cancer, with the objective of enabling personalised treatment at an early stage.

EpiHealth aims to improve our understanding of the causal links behind common diseases, including cancer.

MAD for Cancer is an interdisciplinary programme focusing on the tumour as a complex organ.

The Malmö Cancer Centre studies aim to identify treatment strategies and opportunities for cancer.

The Malmö Diet and Cancer Study is a major cohort study investigating the links between diet and the risk of developing cancer.